1. Home
  2. TEVA vs PUK Comparison

TEVA vs PUK Comparison

Compare TEVA & PUK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • PUK
  • Stock Information
  • Founded
  • TEVA 1901
  • PUK 1848
  • Country
  • TEVA Israel
  • PUK Hong Kong
  • Employees
  • TEVA N/A
  • PUK N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • PUK Life Insurance
  • Sector
  • TEVA Health Care
  • PUK Finance
  • Exchange
  • TEVA Nasdaq
  • PUK Nasdaq
  • Market Cap
  • TEVA 19.2B
  • PUK 22.3B
  • IPO Year
  • TEVA N/A
  • PUK 1990
  • Fundamental
  • Price
  • TEVA $16.92
  • PUK $15.98
  • Analyst Decision
  • TEVA Strong Buy
  • PUK
  • Analyst Count
  • TEVA 8
  • PUK 0
  • Target Price
  • TEVA $19.63
  • PUK N/A
  • AVG Volume (30 Days)
  • TEVA 7.4M
  • PUK 1.4M
  • Earning Date
  • TEVA 11-06-2024
  • PUK 08-28-2024
  • Dividend Yield
  • TEVA N/A
  • PUK 2.64%
  • EPS Growth
  • TEVA N/A
  • PUK N/A
  • EPS
  • TEVA N/A
  • PUK 0.32
  • Revenue
  • TEVA $16,772,000,000.00
  • PUK $10,944,000,000.00
  • Revenue This Year
  • TEVA $4.70
  • PUK N/A
  • Revenue Next Year
  • TEVA $4.47
  • PUK $11.71
  • P/E Ratio
  • TEVA N/A
  • PUK $24.02
  • Revenue Growth
  • TEVA 9.81
  • PUK N/A
  • 52 Week Low
  • TEVA $9.35
  • PUK $15.11
  • 52 Week High
  • TEVA $19.31
  • PUK $23.37
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.51
  • PUK 41.95
  • Support Level
  • TEVA $16.15
  • PUK $15.70
  • Resistance Level
  • TEVA $17.16
  • PUK $16.13
  • Average True Range (ATR)
  • TEVA 0.49
  • PUK 0.25
  • MACD
  • TEVA -0.07
  • PUK -0.02
  • Stochastic Oscillator
  • TEVA 30.38
  • PUK 36.35

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About PUK Prudential Public Limited Company

Originally established as Prudential Mutual Assurance, Investment, and Loan Association in 1848, Prudential plc has moved on a lot since then. Set up to sell life insurance and loans to the middle and then the industrializing and urbanizing working classes, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life in around 1985. During its time as owner of Jackson, Prudential focused on building out a simple chassis-style product portfolio where customers could choose a variety of add-ons. The company also became renowned for its focus on building requisite internal capabilities to support its strong product offerings, including compelling technology and a large and well-trained sales personnel.

Share on Social Networks: